R&D Mind the gap: The need for gender-specific outcome measureme... It is well documented that women face delayed diagnoses, mischaracterised symptoms, and experience more years of ill-health compared to men.
News Meta harvested health data to target ads, jury concludes A jury in the US found that Meta illegally invaded the privacy of users of a health app, with implications for how tech firms handle personal data.
News Gates Foundation puts $2.5bn into 'ignored' women's health The Gates Foundation is ramping up support for women's health research, pumping $2.5bn into new projects in this 'ignored, underfunded' area of R&D.
News Gedeon Richter brings HRT option back to the UK market After a 17-year absence, a dydrogesterone-only hormone replacement therapy (HRT) formulation is available again in the UK market.
R&D Medicine’s blind spot: How clinical trials are failing women From insulin to immunotherapies, clinical trials have powered some of the most important medical breakthroughs of our time.
News Bayer bags first world approval for hot flush therapy Bayer has its first regulatory approval for non-hormonal menopause treatment elinzanetant – in the UK – as it chases down a rival drug from Astellas.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.